Cue Biopharma Inc buy Stifel Nicolaus
Start price
22.03.23
/
50%
€3.00
Target price
22.03.24
€7.41
Performance (%)
-42.17%
End price
23.03.24
€1.74
Summary
This prediction ended on 23.03.24 with a price of €1.74. The BUY prediction by Stifel_Nicolaus for Cue Biopharma Inc performed very badly with a performance of -42.17%. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Cue Biopharma Inc | - | - | - | - |
| iShares Core DAX® | -1,86 % | 0,67 % | 0,92 % | 51,85 % |
| iShares Nasdaq 100 | -3,32 % | 4,99 % | 33,72 % | 86,85 % |
| iShares Nikkei 225® | -2,30 % | 6,13 % | 52,96 % | 63,32 % |
| iShares S&P 500 | -1,31 % | 3,40 % | 24,67 % | 66,11 % |
Comments by Stifel_Nicolaus for this prediction
In the thread Cue Biopharma Inc diskutieren
Cue Biopharma, Inc. (NASDAQ: CUE) had its price target lowered by analysts at Stifel Nicolaus from $9.00 to $8.00. They now have a "buy" rating on the stock.
Ratings data for CUE provided by MarketBeat
In the thread Trading Cue Biopharma Inc
Die von Stifel_Nicolaus gewählte maximale Laufzeit wurde überschritten